Feb 24, 2026 08:00AM
Jan 12, 2026 08:31AM
Jan 12, 2026 08:30AM
Jan 9, 2026 08:30AM
Jan 9, 2026 08:30AM
Dec 4, 2025 08:42AM
Dec 3, 2025 08:01AM Clene reports positive ALS biomarker data for CNM-Au8 drug candidate
Dec 3, 2025 08:00AM
Nov 20, 2025 09:11AM
Nov 13, 2025 08:00AM
Sep 26, 2025 08:50AM
Sep 25, 2025 08:00AM
Sep 10, 2025 08:52AM
Sep 4, 2025 08:30AM Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
Aug 18, 2025 06:41AM
Aug 14, 2025 08:38AM
Jul 1, 2025 09:29AM
Jul 1, 2025 06:53AM
Jun 30, 2025 08:05AM
Jun 30, 2025 08:00AM
May 7, 2025 08:00AM Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights
Mar 25, 2025 06:50AM
Mar 24, 2025 08:00AM
Mar 13, 2025 06:48AM
Mar 12, 2025 08:02AM
Mar 12, 2025 08:00AM
Feb 26, 2025 06:50AM
Feb 25, 2025 08:03AM Clene (CLNN) and APST Enter Into an Agreement to Support FDA’s Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®’s Impact on NfL Reduction
Feb 25, 2025 08:00AM
Dec 19, 2024 08:00AM
Dec 10, 2024 08:30AM
Nov 22, 2024 06:55AM
Nov 14, 2024 07:11AM
Nov 13, 2024 08:00AM
Oct 10, 2024 06:18AM Canaccord Genuity Reiterates Buy Rating on Clene, Inc. (CLNN)
Oct 4, 2024 06:46AM
Oct 1, 2024 04:00PM
Sep 17, 2024 06:57AM
Sep 16, 2024 08:32AM
Sep 16, 2024 08:30AM
Aug 8, 2024 08:00AM
Aug 7, 2024 08:23AM Clene Reports Second Quarter 2024 Financial Results and Recent Operating Highlights
Aug 7, 2024 06:48AM
Aug 6, 2024 08:02AM
Aug 6, 2024 08:00AM
Jul 11, 2024 09:00AM
Jun 24, 2024 06:37AM
Jun 21, 2024 07:10AM
Jun 21, 2024 07:09AM Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome
May 28, 2024 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All